Targeted prodrug design to optimize drug delivery

@article{Han2000TargetedPD,
  title={Targeted prodrug design to optimize drug delivery},
  author={Hyo-Kyung Han and Gordon L Amidon},
  journal={AAPS PharmSci},
  year={2000},
  volume={2},
  pages={48-58}
}
Classical prodrug design often represents a nonspecific chemical approach to mask undesirable drug properties such as limited bioavailability, lack of site specificity, and chemical instability. On the other hand, targeted prodrug design represents a new strategy for directed and efficient drug delivery. Particularly, targeting the prodrugs to a specific enzyme or a specific membrane transporter, or both, has potential as a selective drug delivery system in cancer chemotherapy or as an… CONTINUE READING
64 Citations
79 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 79 references

A monoclonal antibody-ß-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer

  • HJ Haisma, E Boven, M van Muijen, J de Jong, WJ van der Vijgh, HM. Pinedo
  • Br J Cancer
  • 1992
Highly Influential
11 Excerpts

Properties and reactions of N-(alphahydroxyalkyl)-thionamides. Arch Pharm. (Weinheim) 1974;307:748-755

  • H Bohme, KH Ahrens, HH. Hotzel
  • AAPS Pharmsci
  • 2000
2 Excerpts

Similar Papers

Loading similar papers…